Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

People

Daniel J.
Cerqueira

Partner, Corporate

dcerqueira@cravath.com
  • New York+1-212-474-1156
    • E-mail
    • Twitter
    • Facebook
    • LinkedIn
  • PDF
  • Vcard
  • Overview
  • Credentials
  • Featured Work
  • News & Insights

Daniel J. Cerqueira focuses his practice on mergers and acquisitions, corporate governance, activist defense and general corporate matters. Mr. Cerqueira’s clients have included AerCap, Altra, AmerisourceBergen, Ashland, Biogen, Blue Current, Brookfield Asset Management, Buckeye Partners, Cincinnati Bell, Disney, DRI Capital, FS Investments, GreenSky, Hasbro, Hertz, Hibu Group, IBM, Illumina, Occidental Petroleum, Pinnacle Foods, RedHill Biopharma, SMBC Aviation Capital, Southwest Gas, Starwood Hotels and Univision.

Mr. Cerqueira’s notable transactions include representing:

  • Wiz in its pending $32 billion acquisition by Google;
  • Disney in its $85 billion acquisition of 21st Century Fox, overcoming an interloper bid by Comcast to its original $66 billion agreement; the pending combination of its Hulu + Live TV business with Fubo; ESPN’s proposed joint venture with Fox and Warner Bros. Discovery to launch Venu Sports; and ESPN’s strategic alliance with PENN Entertainment to launch ESPN BET;

  • Paramount’s special committee in the pending $28 billion merger with Skydance;
  • The Criterion Collection and Janus Films in their sale to Steven M. Rales;
  • Illumina in its $8 billion acquisition and subsequent spin‑off of GRAIL;
  • DRI Capital in the acquisition of a synthetic royalty interest in the worldwide sales of sebetralstat and related equity investment in KalVista Pharmaceuticals, the acquisition from Editas Medicine of payment streams based on the Cas9 gene‑editing technology for CASGEVY, the expansion of its royalty interest in Omidria, its acquisition of a royalty interest in Orserdu from Eisai, its acquisition of a second royalty interest in Orserdu from Radius Health and the $210 million sale of its TZIELD royalty interest to Sanofi;

  • Hasbro in the sale of its eOne film and TV business to Lionsgate;
  • RedHill Biopharma in its agreement with HealthCare Royalty to extinguish its debt obligations in exchange for Movantik;
  • Altra in its $5 billion acquisition by Regal Rexnord and its $3 billion combination with four operating companies from Fortive’s Automation and Specialty platform;
  • IBM in its acquisitions of Randori, ReaQta, McD Tech Labs from McDonald’s, and BoxBoat and the sale of its marketing platform and commerce software offerings to Centerbridge;

  • SMBC Aviation Capital in its $6.7 billion acquisition of Goshawk Aviation;
  • GreenSky in its $2.24 billion acquisition by Goldman Sachs;
  • Hibu Group in the sale of its U.S. business to H.I.G. Capital;
  • Univision in its sale of a majority stake to Searchlight and ForgeLight;
  • Cincinnati Bell in its $2.9 billion acquisition by Macquarie Infrastructure;
  • Viacom’s transaction committee in the $30 billion merger with CBS;
  • Buckeye Partners in its $10.3 billion acquisition by IFM and the $975 million sale of its 50% interest in VTTI to Vitol and IFM;
  • Occidental Petroleum in its $57 billion acquisition of Anadarko, topping Anadarko’s original agreement with Chevron, the $8.8 billion sale of Anadarko’s African assets to Total and the $10 billion investment by Berkshire Hathaway;
  • FS Investments in the transition of the management of its business development company (BDC) platform to investment advisory partnerships with EIG Global Energy Partners and KKR;
  • Brookfield Asset Management in its $3.8 billion acquisition of a controlling stake in TerraForm Power and its $1.3 billion acquisition of TerraForm Global;
  • D+H in its C$4.8 billion sale to Vista Equity Partners;
  • Biogen in its $1.25 billion settlement and license agreement with Forward Pharma;
  • Starwood Hotels in its $13.3 billion sale to Marriott International and in connection with a competing, unsolicited acquisition proposal from a consortium consisting of Anbang Insurance Group, J.C. Flowers & Co. and Primavera Capital;
  • Lindsay Goldberg in its sale of PAE to Platinum Equity;
  • BDT Capital Partners in its acquisition of a majority interest in Alliance Laundry Systems from Ontario Teachers’ Pension Plan;
  • AmerisourceBergen in its $2.5 billion acquisition of MWI Veterinary Supply; and
  • AerCap in its $28 billion acquisition of International Lease Finance from AIG.

Mr. Cerqueira has also represented numerous companies in defending against hedge fund activism. Notable examples include representing:

  • ARIAD Pharmaceuticals in the adoption of its shareholder rights plan and in its settlement agreement with Sarissa Capital;
  • Ashland in its proxy contest and subsequent settlement agreement with Cruiser Capital;
  • Disney in its support agreement with Third Point and its successful proxy contests against Trian and Blackwells;
  • Hasbro in its successful proxy contest against Alta Fox Capital;
  • Hertz in the adoption of its shareholder rights plan in response to an activist investor reported to be Carl Icahn; 
  • Illumina in its proxy contest against Carl Icahn and its interactions with Corvex; and
  • Southwest Gas in its proxy fight and settlement agreement with, and its response to an unsolicited tender offer from, Carl Icahn.

Mr. Cerqueira was named an M&A “Rising Star” by The Deal in 2021 and has been recognized for his work in mergers and acquisitions by IFLR1000 and for his work in activism defense by The Legal 500 US. He has also been recognized as one of “Hollywood’s Top Dealmakers” by The Hollywood Reporter. Additionally, Lawdragon has included Mr. Cerqueira among the “500 Leading Dealmakers in America” and “500 Leading Global Entertainment, Sports & Media Lawyers.”

Mr. Cerqueira is a fellow of the American Bar Foundation, a member of the International Bar Association and serves on the Mergers, Acquisitions & Corporate Control Contests Committee of the New York City Bar Association. He is a frequent speaker on legal developments in mergers and acquisitions and shareholder activism defense, having participated in events hosted by the American Bar Association, the International Bar Association and the Practising Law Institute, among others. Mr. Cerqueira has also spoken at the Cornell Tech Board Institute and DealFlow Events’ Activist Investor Conference.

Mr. Cerqueira is from Mansfield, Massachusetts. He received a B.A. from Cornell University in 2010, where he was elected to Phi Beta Kappa, and a J.D. magna cum laude from Harvard Law School in 2013, where he was a Submissions Editor and an Executive Editor of the Business Law Review.

Mr. Cerqueira joined Cravath in 2013 and was elected a partner in 2020.

Mr. Cerqueira’s notable transactions include representing:

  • Wiz in its pending $32 billion acquisition by Google;
  • Disney in its $85 billion acquisition of 21st Century Fox, overcoming an interloper bid by Comcast to its original $66 billion agreement; the pending combination of its Hulu + Live TV business with Fubo; ESPN’s proposed joint venture with Fox and Warner Bros. Discovery to launch Venu Sports; and ESPN’s strategic alliance with PENN Entertainment to launch ESPN BET;

  • Paramount’s special committee in the pending $28 billion merger with Skydance;
  • The Criterion Collection and Janus Films in their sale to Steven M. Rales;
  • Illumina in its $8 billion acquisition and subsequent spin‑off of GRAIL;
  • DRI Capital in the acquisition of a synthetic royalty interest in the worldwide sales of sebetralstat and related equity investment in KalVista Pharmaceuticals, the acquisition from Editas Medicine of payment streams based on the Cas9 gene‑editing technology for CASGEVY, the expansion of its royalty interest in Omidria, its acquisition of a royalty interest in Orserdu from Eisai, its acquisition of a second royalty interest in Orserdu from Radius Health and the $210 million sale of its TZIELD royalty interest to Sanofi;

  • Hasbro in the sale of its eOne film and TV business to Lionsgate;
  • RedHill Biopharma in its agreement with HealthCare Royalty to extinguish its debt obligations in exchange for Movantik;
  • Altra in its $5 billion acquisition by Regal Rexnord and its $3 billion combination with four operating companies from Fortive’s Automation and Specialty platform;
  • IBM in its acquisitions of Randori, ReaQta, McD Tech Labs from McDonald’s, and BoxBoat and the sale of its marketing platform and commerce software offerings to Centerbridge;

  • SMBC Aviation Capital in its $6.7 billion acquisition of Goshawk Aviation;
  • GreenSky in its $2.24 billion acquisition by Goldman Sachs;
  • Hibu Group in the sale of its U.S. business to H.I.G. Capital;
  • Univision in its sale of a majority stake to Searchlight and ForgeLight;
  • Cincinnati Bell in its $2.9 billion acquisition by Macquarie Infrastructure;
  • Viacom’s transaction committee in the $30 billion merger with CBS;
  • Buckeye Partners in its $10.3 billion acquisition by IFM and the $975 million sale of its 50% interest in VTTI to Vitol and IFM;
  • Occidental Petroleum in its $57 billion acquisition of Anadarko, topping Anadarko’s original agreement with Chevron, the $8.8 billion sale of Anadarko’s African assets to Total and the $10 billion investment by Berkshire Hathaway;
  • FS Investments in the transition of the management of its business development company (BDC) platform to investment advisory partnerships with EIG Global Energy Partners and KKR;
  • Brookfield Asset Management in its $3.8 billion acquisition of a controlling stake in TerraForm Power and its $1.3 billion acquisition of TerraForm Global;
  • D+H in its C$4.8 billion sale to Vista Equity Partners;
  • Biogen in its $1.25 billion settlement and license agreement with Forward Pharma;
  • Starwood Hotels in its $13.3 billion sale to Marriott International and in connection with a competing, unsolicited acquisition proposal from a consortium consisting of Anbang Insurance Group, J.C. Flowers & Co. and Primavera Capital;
  • Lindsay Goldberg in its sale of PAE to Platinum Equity;
  • BDT Capital Partners in its acquisition of a majority interest in Alliance Laundry Systems from Ontario Teachers’ Pension Plan;
  • AmerisourceBergen in its $2.5 billion acquisition of MWI Veterinary Supply; and
  • AerCap in its $28 billion acquisition of International Lease Finance from AIG.

Mr. Cerqueira has also represented numerous companies in defending against hedge fund activism. Notable examples include representing:

  • ARIAD Pharmaceuticals in the adoption of its shareholder rights plan and in its settlement agreement with Sarissa Capital;
  • Ashland in its proxy contest and subsequent settlement agreement with Cruiser Capital;
  • Disney in its support agreement with Third Point and its successful proxy contests against Trian and Blackwells;
  • Hasbro in its successful proxy contest against Alta Fox Capital;
  • Hertz in the adoption of its shareholder rights plan in response to an activist investor reported to be Carl Icahn; 
  • Illumina in its proxy contest against Carl Icahn and its interactions with Corvex; and
  • Southwest Gas in its proxy fight and settlement agreement with, and its response to an unsolicited tender offer from, Carl Icahn.

Mr. Cerqueira was named an M&A “Rising Star” by The Deal in 2021 and has been recognized for his work in mergers and acquisitions by IFLR1000 and for his work in activism defense by The Legal 500 US. He has also been recognized as one of “Hollywood’s Top Dealmakers” by The Hollywood Reporter. Additionally, Lawdragon has included Mr. Cerqueira among the “500 Leading Dealmakers in America” and “500 Leading Global Entertainment, Sports & Media Lawyers.”

Mr. Cerqueira is a fellow of the American Bar Foundation, a member of the International Bar Association and serves on the Mergers, Acquisitions & Corporate Control Contests Committee of the New York City Bar Association. He is a frequent speaker on legal developments in mergers and acquisitions and shareholder activism defense, having participated in events hosted by the American Bar Association, the International Bar Association and the Practising Law Institute, among others. Mr. Cerqueira has also spoken at the Cornell Tech Board Institute and DealFlow Events’ Activist Investor Conference.

Mr. Cerqueira is from Mansfield, Massachusetts. He received a B.A. from Cornell University in 2010, where he was elected to Phi Beta Kappa, and a J.D. magna cum laude from Harvard Law School in 2013, where he was a Submissions Editor and an Executive Editor of the Business Law Review.

Mr. Cerqueira joined Cravath in 2013 and was elected a partner in 2020.

Education

  • J.D., 2013, Harvard Law School
    magna cum laude
  • B.A., 2010, Cornell University
    Phi Beta Kappa

Admitted In

  • New York

Professional Affiliations

American Bar Association

American Bar Foundation

  • Fellow

International Bar Association

New York City Bar Association

  • Mergers, Acquisitions & Corporate Control Contests Committee

Rankings

The Dealmaker Quarterly

  • Rising Star (2021)

The Hollywood Reporter

  • Top Dealmakers (2024)

IFLR1000

  • Mergers and Acquisitions - US (2024)

Lawdragon

  • 500 Leading Dealmakers in America (2024, 2023)
  • 500 Leading Global Entertainment, Sports & Media Lawyers (2025)
  • 500 X – The Next Generation (2024, 2023)

The Legal 500 US

  • Shareholder Activism: Advice to Boards (2024, 2023)

 

Deals & Cases

March 18, 2025

Wiz’s $32 Billion Acquisition by Google

On March 18, 2025, Wiz, Inc. (“Wiz”), a leading cloud security platform headquartered in New York, and Google LLC (“Google”) announced they have signed a definitive agreement for Google to acquire Wiz for $32 billion, subject to closing adjustments, in an all‑cash transaction. Once closed, Wiz will join Google Cloud. Cravath is representing Wiz as regulatory counsel in connection with the transaction.

Deals & Cases

January 06, 2025

Disney’s Combination of its Hulu + Live TV Business with Fubo

On January 6, 2025, The Walt Disney Company (“Disney”) and FuboTV Inc. (“Fubo) announced that they have entered into a definitive agreement for Disney to combine its Hulu + Live TV business with Fubo, forming a combined virtual MVPD company of which Disney will become the majority owner.

Deals & Cases

November 04, 2024

DRI Healthcare Trust’s Acquisition of a Synthetic Royalty Interest in the Worldwide Sales of Sebetralstat and Equity Investment in KalVista Pharmaceuticals

On November 4, 2024, DRI Healthcare Trust (“the Trust”), a global leader in providing financing to advance innovation in the life sciences industry, announced it has acquired a royalty interest in the worldwide net sales of all formulations of sebetralstat, an investigational oral plasma kallikrein inhibitor for the treatment of Hereditary Angioedema, from KalVista Pharmaceuticals ("KalVista") for an aggregate purchase price of up to $179 million, comprised of a $100 million upfront payment, up to $57 million in a sales-based milestone payment and a one-time $22 million optional payment. Additionally, the Trust is making a $5 million investment in KalVista’s common stock in a private placement transaction. Cravath is representing DRI Healthcare Trust in connection with the transaction.

Deals & Cases

October 04, 2024

DRI Healthcare Trust’s Acquisition of Payment Streams Based on the Cas9 Gene‑Editing Technology for CASGEVY®

On October 3, 2024, DRI Healthcare Trust, a global leader in providing financing to advance innovation in the life sciences industry, announced that one of its wholly owned subsidiaries acquired a portion of Editas Medicine, Inc.'s payment rights under a non‑exclusive license of Editas' Cas9 gene‑editing technology for CASGEVY®, the only approved gene‑edited cell therapy for sickle cell disease and transfusion‑dependent beta thalassemia, for an upfront purchase price of $57 million. The transaction entitles DRI Healthcare to specific payments based on a sublicensing agreement between Editas and Vertex Pharmaceuticals Incorporated. The payments include a share of the annual license fees that Vertex pays to Editas, which can range from $5 million to $40 million, including certain sales‑based annual license fee increases, and a portion of a $50 million contingent payment to which Editas is eligible under the Vertex sublicensing agreement. Cravath is representing DRI Healthcare in connection with the transaction.

Deals & Cases

July 08, 2024

Paramount’s $28 Billion Merger Agreement with Skydance

On July 7, 2024, Paramount Global (“Paramount”), a leading global media, streaming and entertainment company, and Skydance Media (“Skydance”), a diversified media company founded to create high-quality, event-level entertainment for global audiences, announced that they have entered into a definitive agreement to form “New Paramount,” a next-generation media and technology leader, through a two-step transaction including the acquisition of National Amusements, Inc. (“NAI”), which holds the controlling share stake in Paramount, and subsequently a merger of Skydance and Paramount. Under the terms of the agreement, which has been approved by the Paramount Board of Directors, acting on the unanimous recommendation of the Special Committee of independent directors, and by NAI, Skydance will merge with Paramount in a transaction valuing New Paramount at an enterprise value of approximately $28 billion. Existing Skydance investors will receive 317 million newly issued Class B shares in New Paramount valuing Skydance at $4.75 billion based on $15 per Paramount Class B share. The Skydance Investor Group will invest up to $6 billion in offers to Class A and Class B stockholders, and use the additional capital to paydown debt and re-capitalize the balance sheet of New Paramount. NAI and its owners have entered into a definitive agreement to sell NAI to Skydance IG for $2.4 billion on a cash-free, debt-free basis. Cravath is representing the Paramount Special Committee in connection with the agreement.

Activities

May 01, 2025

Dan Cerqueira Co‑Chairs Panel at the American Bar Association’s 2025 International Law Section Annual Conference

On April 30, 2025, Cravath partner Daniel J. Cerqueira participated in the American Bar Association’s 2025 International Law Section Annual Conference, which was held from April 28 to May 1 in New York. The event hosted international attorneys from law firms, private organizations and global governmental institutions to discuss topics related to the theme of “Adapting to Today's International Legal Challenges.”

Publications

April 08, 2025

Richard Hall and Dan Cerqueira Contribute to Legal 500’s 2025 Country Comparative M&A Guide

Cravath partner Richard Hall served as contributing editor of Legal 500’s 2025 “Mergers & Acquisitions Country Comparative Guide,” which was published in April 2025. The guide provides a pragmatic overview of M&A laws and regulations across a variety of jurisdictions. Together with Richard, partner Daniel J. Cerqueira authored the United States chapter of the guide, which reviews M&A trends, the current state of the market and key considerations for companies and shareholders.

Activities

March 07, 2025

Eight Cravath Partners Named to Lawdragon’s Inaugural List of “500 Leading Global Entertainment, Sports & Media Lawyers”

On March 7, 2025, Cravath partners Faiza J. Saeed, Antony L. Ryan, Gary A. Bornstein, Wes Earnhardt, Yonatan Even, Daniel J. Cerqueira, David H. Korn and Claudia J. Ricciardi were named to Lawdragon’s inaugural list of “500 Leading Global Entertainment, Sports & Media Lawyers” in recognition of their work across Cravath’s Corporate and Litigation Departments advising clients in the entertainment, sports and media industries. The list, assembled based on research and vetting by peers, highlights leading lawyers who use their expertise to advise “hugely valuable clients as they extend their reach in a multimedia world.”

Activities

February 03, 2025

Law360 Names Cravath a 2024 “Media & Entertainment Practice Group of the Year”

On January 30, 2025, Cravath was featured by Law360 as a “Media & Entertainment Practice Group of the Year.” The article highlights the Firm’s work across its Corporate and Litigation departments representing clients in the industry, including Disney in litigation stemming from its 2018 acquisition of Twenty‑First Century Fox, Inc., in which Cravath had also represented the company, and the Paramount Special Committee in connection with Paramount’s $28 billion merger agreement with Skydance.

Activities

December 10, 2024

Faiza Saeed, Dan Cerqueira and Claudia Ricciardi Recognized in The Hollywood Reporter’s List of Hollywood’s Top Dealmakers of 2024

Cravath partners Faiza J. Saeed, Daniel J. Cerqueira and Claudia J. Ricciardi were recognized in The Hollywood Reporter’s list of “Hollywood’s Top Dealmakers of 2024,” which was published in the December 4, 2024 issue of The Hollywood Reporter Magazine. The feature highlighted the dealmakers who made “the most impactful and intriguing mergers and acquisitions” happen in the industry this year. Faiza, Dan and Claudia were noted for their representation of the Paramount Special Committee in its $28 billion merger agreement with Skydance. Faiza and Claudia were also noted for their representation of the independent Special Committee of Endeavor’s board of directors in its $25 billion take private acquisition by Silver Lake.

Daniel J. Cerqueira focuses his practice on mergers and acquisitions, corporate governance, activist defense and general corporate matters. Mr. Cerqueira’s clients have included AerCap, Altra, AmerisourceBergen, Ashland, Biogen, Blue Current, Brookfield Asset Management, Buckeye Partners, Cincinnati Bell, Disney, DRI Capital, FS Investments, GreenSky, Hasbro, Hertz, Hibu Group, IBM, Illumina, Occidental Petroleum, Pinnacle Foods, RedHill Biopharma, SMBC Aviation Capital, Southwest Gas, Starwood Hotels and Univision.

Mr. Cerqueira’s notable transactions include representing:

  • Wiz in its pending $32 billion acquisition by Google;
  • Disney in its $85 billion acquisition of 21st Century Fox, overcoming an interloper bid by Comcast to its original $66 billion agreement; the pending combination of its Hulu + Live TV business with Fubo; ESPN’s proposed joint venture with Fox and Warner Bros. Discovery to launch Venu Sports; and ESPN’s strategic alliance with PENN Entertainment to launch ESPN BET;

  • Paramount’s special committee in the pending $28 billion merger with Skydance;
  • The Criterion Collection and Janus Films in their sale to Steven M. Rales;
  • Illumina in its $8 billion acquisition and subsequent spin‑off of GRAIL;
  • DRI Capital in the acquisition of a synthetic royalty interest in the worldwide sales of sebetralstat and related equity investment in KalVista Pharmaceuticals, the acquisition from Editas Medicine of payment streams based on the Cas9 gene‑editing technology for CASGEVY, the expansion of its royalty interest in Omidria, its acquisition of a royalty interest in Orserdu from Eisai, its acquisition of a second royalty interest in Orserdu from Radius Health and the $210 million sale of its TZIELD royalty interest to Sanofi;

  • Hasbro in the sale of its eOne film and TV business to Lionsgate;
  • RedHill Biopharma in its agreement with HealthCare Royalty to extinguish its debt obligations in exchange for Movantik;
  • Altra in its $5 billion acquisition by Regal Rexnord and its $3 billion combination with four operating companies from Fortive’s Automation and Specialty platform;
  • IBM in its acquisitions of Randori, ReaQta, McD Tech Labs from McDonald’s, and BoxBoat and the sale of its marketing platform and commerce software offerings to Centerbridge;

  • SMBC Aviation Capital in its $6.7 billion acquisition of Goshawk Aviation;
  • GreenSky in its $2.24 billion acquisition by Goldman Sachs;
  • Hibu Group in the sale of its U.S. business to H.I.G. Capital;
  • Univision in its sale of a majority stake to Searchlight and ForgeLight;
  • Cincinnati Bell in its $2.9 billion acquisition by Macquarie Infrastructure;
  • Viacom’s transaction committee in the $30 billion merger with CBS;
  • Buckeye Partners in its $10.3 billion acquisition by IFM and the $975 million sale of its 50% interest in VTTI to Vitol and IFM;
  • Occidental Petroleum in its $57 billion acquisition of Anadarko, topping Anadarko’s original agreement with Chevron, the $8.8 billion sale of Anadarko’s African assets to Total and the $10 billion investment by Berkshire Hathaway;
  • FS Investments in the transition of the management of its business development company (BDC) platform to investment advisory partnerships with EIG Global Energy Partners and KKR;
  • Brookfield Asset Management in its $3.8 billion acquisition of a controlling stake in TerraForm Power and its $1.3 billion acquisition of TerraForm Global;
  • D+H in its C$4.8 billion sale to Vista Equity Partners;
  • Biogen in its $1.25 billion settlement and license agreement with Forward Pharma;
  • Starwood Hotels in its $13.3 billion sale to Marriott International and in connection with a competing, unsolicited acquisition proposal from a consortium consisting of Anbang Insurance Group, J.C. Flowers & Co. and Primavera Capital;
  • Lindsay Goldberg in its sale of PAE to Platinum Equity;
  • BDT Capital Partners in its acquisition of a majority interest in Alliance Laundry Systems from Ontario Teachers’ Pension Plan;
  • AmerisourceBergen in its $2.5 billion acquisition of MWI Veterinary Supply; and
  • AerCap in its $28 billion acquisition of International Lease Finance from AIG.

Mr. Cerqueira has also represented numerous companies in defending against hedge fund activism. Notable examples include representing:

  • ARIAD Pharmaceuticals in the adoption of its shareholder rights plan and in its settlement agreement with Sarissa Capital;
  • Ashland in its proxy contest and subsequent settlement agreement with Cruiser Capital;
  • Disney in its support agreement with Third Point and its successful proxy contests against Trian and Blackwells;
  • Hasbro in its successful proxy contest against Alta Fox Capital;
  • Hertz in the adoption of its shareholder rights plan in response to an activist investor reported to be Carl Icahn; 
  • Illumina in its proxy contest against Carl Icahn and its interactions with Corvex; and
  • Southwest Gas in its proxy fight and settlement agreement with, and its response to an unsolicited tender offer from, Carl Icahn.

Mr. Cerqueira was named an M&A “Rising Star” by The Deal in 2021 and has been recognized for his work in mergers and acquisitions by IFLR1000 and for his work in activism defense by The Legal 500 US. He has also been recognized as one of “Hollywood’s Top Dealmakers” by The Hollywood Reporter. Additionally, Lawdragon has included Mr. Cerqueira among the “500 Leading Dealmakers in America” and “500 Leading Global Entertainment, Sports & Media Lawyers.”

Mr. Cerqueira is a fellow of the American Bar Foundation, a member of the International Bar Association and serves on the Mergers, Acquisitions & Corporate Control Contests Committee of the New York City Bar Association. He is a frequent speaker on legal developments in mergers and acquisitions and shareholder activism defense, having participated in events hosted by the American Bar Association, the International Bar Association and the Practising Law Institute, among others. Mr. Cerqueira has also spoken at the Cornell Tech Board Institute and DealFlow Events’ Activist Investor Conference.

Mr. Cerqueira is from Mansfield, Massachusetts. He received a B.A. from Cornell University in 2010, where he was elected to Phi Beta Kappa, and a J.D. magna cum laude from Harvard Law School in 2013, where he was a Submissions Editor and an Executive Editor of the Business Law Review.

Mr. Cerqueira joined Cravath in 2013 and was elected a partner in 2020.

Mr. Cerqueira’s notable transactions include representing:

  • Wiz in its pending $32 billion acquisition by Google;
  • Disney in its $85 billion acquisition of 21st Century Fox, overcoming an interloper bid by Comcast to its original $66 billion agreement; the pending combination of its Hulu + Live TV business with Fubo; ESPN’s proposed joint venture with Fox and Warner Bros. Discovery to launch Venu Sports; and ESPN’s strategic alliance with PENN Entertainment to launch ESPN BET;

  • Paramount’s special committee in the pending $28 billion merger with Skydance;
  • The Criterion Collection and Janus Films in their sale to Steven M. Rales;
  • Illumina in its $8 billion acquisition and subsequent spin‑off of GRAIL;
  • DRI Capital in the acquisition of a synthetic royalty interest in the worldwide sales of sebetralstat and related equity investment in KalVista Pharmaceuticals, the acquisition from Editas Medicine of payment streams based on the Cas9 gene‑editing technology for CASGEVY, the expansion of its royalty interest in Omidria, its acquisition of a royalty interest in Orserdu from Eisai, its acquisition of a second royalty interest in Orserdu from Radius Health and the $210 million sale of its TZIELD royalty interest to Sanofi;

  • Hasbro in the sale of its eOne film and TV business to Lionsgate;
  • RedHill Biopharma in its agreement with HealthCare Royalty to extinguish its debt obligations in exchange for Movantik;
  • Altra in its $5 billion acquisition by Regal Rexnord and its $3 billion combination with four operating companies from Fortive’s Automation and Specialty platform;
  • IBM in its acquisitions of Randori, ReaQta, McD Tech Labs from McDonald’s, and BoxBoat and the sale of its marketing platform and commerce software offerings to Centerbridge;

  • SMBC Aviation Capital in its $6.7 billion acquisition of Goshawk Aviation;
  • GreenSky in its $2.24 billion acquisition by Goldman Sachs;
  • Hibu Group in the sale of its U.S. business to H.I.G. Capital;
  • Univision in its sale of a majority stake to Searchlight and ForgeLight;
  • Cincinnati Bell in its $2.9 billion acquisition by Macquarie Infrastructure;
  • Viacom’s transaction committee in the $30 billion merger with CBS;
  • Buckeye Partners in its $10.3 billion acquisition by IFM and the $975 million sale of its 50% interest in VTTI to Vitol and IFM;
  • Occidental Petroleum in its $57 billion acquisition of Anadarko, topping Anadarko’s original agreement with Chevron, the $8.8 billion sale of Anadarko’s African assets to Total and the $10 billion investment by Berkshire Hathaway;
  • FS Investments in the transition of the management of its business development company (BDC) platform to investment advisory partnerships with EIG Global Energy Partners and KKR;
  • Brookfield Asset Management in its $3.8 billion acquisition of a controlling stake in TerraForm Power and its $1.3 billion acquisition of TerraForm Global;
  • D+H in its C$4.8 billion sale to Vista Equity Partners;
  • Biogen in its $1.25 billion settlement and license agreement with Forward Pharma;
  • Starwood Hotels in its $13.3 billion sale to Marriott International and in connection with a competing, unsolicited acquisition proposal from a consortium consisting of Anbang Insurance Group, J.C. Flowers & Co. and Primavera Capital;
  • Lindsay Goldberg in its sale of PAE to Platinum Equity;
  • BDT Capital Partners in its acquisition of a majority interest in Alliance Laundry Systems from Ontario Teachers’ Pension Plan;
  • AmerisourceBergen in its $2.5 billion acquisition of MWI Veterinary Supply; and
  • AerCap in its $28 billion acquisition of International Lease Finance from AIG.

Mr. Cerqueira has also represented numerous companies in defending against hedge fund activism. Notable examples include representing:

  • ARIAD Pharmaceuticals in the adoption of its shareholder rights plan and in its settlement agreement with Sarissa Capital;
  • Ashland in its proxy contest and subsequent settlement agreement with Cruiser Capital;
  • Disney in its support agreement with Third Point and its successful proxy contests against Trian and Blackwells;
  • Hasbro in its successful proxy contest against Alta Fox Capital;
  • Hertz in the adoption of its shareholder rights plan in response to an activist investor reported to be Carl Icahn; 
  • Illumina in its proxy contest against Carl Icahn and its interactions with Corvex; and
  • Southwest Gas in its proxy fight and settlement agreement with, and its response to an unsolicited tender offer from, Carl Icahn.

Mr. Cerqueira was named an M&A “Rising Star” by The Deal in 2021 and has been recognized for his work in mergers and acquisitions by IFLR1000 and for his work in activism defense by The Legal 500 US. He has also been recognized as one of “Hollywood’s Top Dealmakers” by The Hollywood Reporter. Additionally, Lawdragon has included Mr. Cerqueira among the “500 Leading Dealmakers in America” and “500 Leading Global Entertainment, Sports & Media Lawyers.”

Mr. Cerqueira is a fellow of the American Bar Foundation, a member of the International Bar Association and serves on the Mergers, Acquisitions & Corporate Control Contests Committee of the New York City Bar Association. He is a frequent speaker on legal developments in mergers and acquisitions and shareholder activism defense, having participated in events hosted by the American Bar Association, the International Bar Association and the Practising Law Institute, among others. Mr. Cerqueira has also spoken at the Cornell Tech Board Institute and DealFlow Events’ Activist Investor Conference.

Mr. Cerqueira is from Mansfield, Massachusetts. He received a B.A. from Cornell University in 2010, where he was elected to Phi Beta Kappa, and a J.D. magna cum laude from Harvard Law School in 2013, where he was a Submissions Editor and an Executive Editor of the Business Law Review.

Mr. Cerqueira joined Cravath in 2013 and was elected a partner in 2020.

Education

  • J.D., 2013, Harvard Law School
    magna cum laude
  • B.A., 2010, Cornell University
    Phi Beta Kappa

Admitted In

  • New York

Professional Affiliations

American Bar Association

American Bar Foundation

  • Fellow

International Bar Association

New York City Bar Association

  • Mergers, Acquisitions & Corporate Control Contests Committee

Rankings

The Dealmaker Quarterly

  • Rising Star (2021)

The Hollywood Reporter

  • Top Dealmakers (2024)

IFLR1000

  • Mergers and Acquisitions - US (2024)

Lawdragon

  • 500 Leading Dealmakers in America (2024, 2023)
  • 500 Leading Global Entertainment, Sports & Media Lawyers (2025)
  • 500 X – The Next Generation (2024, 2023)

The Legal 500 US

  • Shareholder Activism: Advice to Boards (2024, 2023)

 

Deals & Cases

March 18, 2025

Wiz’s $32 Billion Acquisition by Google

On March 18, 2025, Wiz, Inc. (“Wiz”), a leading cloud security platform headquartered in New York, and Google LLC (“Google”) announced they have signed a definitive agreement for Google to acquire Wiz for $32 billion, subject to closing adjustments, in an all‑cash transaction. Once closed, Wiz will join Google Cloud. Cravath is representing Wiz as regulatory counsel in connection with the transaction.

Deals & Cases

January 06, 2025

Disney’s Combination of its Hulu + Live TV Business with Fubo

On January 6, 2025, The Walt Disney Company (“Disney”) and FuboTV Inc. (“Fubo) announced that they have entered into a definitive agreement for Disney to combine its Hulu + Live TV business with Fubo, forming a combined virtual MVPD company of which Disney will become the majority owner.

Deals & Cases

November 04, 2024

DRI Healthcare Trust’s Acquisition of a Synthetic Royalty Interest in the Worldwide Sales of Sebetralstat and Equity Investment in KalVista Pharmaceuticals

On November 4, 2024, DRI Healthcare Trust (“the Trust”), a global leader in providing financing to advance innovation in the life sciences industry, announced it has acquired a royalty interest in the worldwide net sales of all formulations of sebetralstat, an investigational oral plasma kallikrein inhibitor for the treatment of Hereditary Angioedema, from KalVista Pharmaceuticals ("KalVista") for an aggregate purchase price of up to $179 million, comprised of a $100 million upfront payment, up to $57 million in a sales-based milestone payment and a one-time $22 million optional payment. Additionally, the Trust is making a $5 million investment in KalVista’s common stock in a private placement transaction. Cravath is representing DRI Healthcare Trust in connection with the transaction.

Deals & Cases

October 04, 2024

DRI Healthcare Trust’s Acquisition of Payment Streams Based on the Cas9 Gene‑Editing Technology for CASGEVY®

On October 3, 2024, DRI Healthcare Trust, a global leader in providing financing to advance innovation in the life sciences industry, announced that one of its wholly owned subsidiaries acquired a portion of Editas Medicine, Inc.'s payment rights under a non‑exclusive license of Editas' Cas9 gene‑editing technology for CASGEVY®, the only approved gene‑edited cell therapy for sickle cell disease and transfusion‑dependent beta thalassemia, for an upfront purchase price of $57 million. The transaction entitles DRI Healthcare to specific payments based on a sublicensing agreement between Editas and Vertex Pharmaceuticals Incorporated. The payments include a share of the annual license fees that Vertex pays to Editas, which can range from $5 million to $40 million, including certain sales‑based annual license fee increases, and a portion of a $50 million contingent payment to which Editas is eligible under the Vertex sublicensing agreement. Cravath is representing DRI Healthcare in connection with the transaction.

Deals & Cases

July 08, 2024

Paramount’s $28 Billion Merger Agreement with Skydance

On July 7, 2024, Paramount Global (“Paramount”), a leading global media, streaming and entertainment company, and Skydance Media (“Skydance”), a diversified media company founded to create high-quality, event-level entertainment for global audiences, announced that they have entered into a definitive agreement to form “New Paramount,” a next-generation media and technology leader, through a two-step transaction including the acquisition of National Amusements, Inc. (“NAI”), which holds the controlling share stake in Paramount, and subsequently a merger of Skydance and Paramount. Under the terms of the agreement, which has been approved by the Paramount Board of Directors, acting on the unanimous recommendation of the Special Committee of independent directors, and by NAI, Skydance will merge with Paramount in a transaction valuing New Paramount at an enterprise value of approximately $28 billion. Existing Skydance investors will receive 317 million newly issued Class B shares in New Paramount valuing Skydance at $4.75 billion based on $15 per Paramount Class B share. The Skydance Investor Group will invest up to $6 billion in offers to Class A and Class B stockholders, and use the additional capital to paydown debt and re-capitalize the balance sheet of New Paramount. NAI and its owners have entered into a definitive agreement to sell NAI to Skydance IG for $2.4 billion on a cash-free, debt-free basis. Cravath is representing the Paramount Special Committee in connection with the agreement.

Activities

May 01, 2025

Dan Cerqueira Co‑Chairs Panel at the American Bar Association’s 2025 International Law Section Annual Conference

On April 30, 2025, Cravath partner Daniel J. Cerqueira participated in the American Bar Association’s 2025 International Law Section Annual Conference, which was held from April 28 to May 1 in New York. The event hosted international attorneys from law firms, private organizations and global governmental institutions to discuss topics related to the theme of “Adapting to Today's International Legal Challenges.”

Publications

April 08, 2025

Richard Hall and Dan Cerqueira Contribute to Legal 500’s 2025 Country Comparative M&A Guide

Cravath partner Richard Hall served as contributing editor of Legal 500’s 2025 “Mergers & Acquisitions Country Comparative Guide,” which was published in April 2025. The guide provides a pragmatic overview of M&A laws and regulations across a variety of jurisdictions. Together with Richard, partner Daniel J. Cerqueira authored the United States chapter of the guide, which reviews M&A trends, the current state of the market and key considerations for companies and shareholders.

Activities

March 07, 2025

Eight Cravath Partners Named to Lawdragon’s Inaugural List of “500 Leading Global Entertainment, Sports & Media Lawyers”

On March 7, 2025, Cravath partners Faiza J. Saeed, Antony L. Ryan, Gary A. Bornstein, Wes Earnhardt, Yonatan Even, Daniel J. Cerqueira, David H. Korn and Claudia J. Ricciardi were named to Lawdragon’s inaugural list of “500 Leading Global Entertainment, Sports & Media Lawyers” in recognition of their work across Cravath’s Corporate and Litigation Departments advising clients in the entertainment, sports and media industries. The list, assembled based on research and vetting by peers, highlights leading lawyers who use their expertise to advise “hugely valuable clients as they extend their reach in a multimedia world.”

Activities

February 03, 2025

Law360 Names Cravath a 2024 “Media & Entertainment Practice Group of the Year”

On January 30, 2025, Cravath was featured by Law360 as a “Media & Entertainment Practice Group of the Year.” The article highlights the Firm’s work across its Corporate and Litigation departments representing clients in the industry, including Disney in litigation stemming from its 2018 acquisition of Twenty‑First Century Fox, Inc., in which Cravath had also represented the company, and the Paramount Special Committee in connection with Paramount’s $28 billion merger agreement with Skydance.

Activities

December 10, 2024

Faiza Saeed, Dan Cerqueira and Claudia Ricciardi Recognized in The Hollywood Reporter’s List of Hollywood’s Top Dealmakers of 2024

Cravath partners Faiza J. Saeed, Daniel J. Cerqueira and Claudia J. Ricciardi were recognized in The Hollywood Reporter’s list of “Hollywood’s Top Dealmakers of 2024,” which was published in the December 4, 2024 issue of The Hollywood Reporter Magazine. The feature highlighted the dealmakers who made “the most impactful and intriguing mergers and acquisitions” happen in the industry this year. Faiza, Dan and Claudia were noted for their representation of the Paramount Special Committee in its $28 billion merger agreement with Skydance. Faiza and Claudia were also noted for their representation of the independent Special Committee of Endeavor’s board of directors in its $25 billion take private acquisition by Silver Lake.

Cravath Bicentennial

Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

Explore

Cravath, Swaine & Moore LLP Logo
  • CONTACT US
  • OUR STORY
  • ALUMNI PORTAL
  • DISCLAIMERS & NOTICES

Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.